Consortium

International and public private collaboration

PERISCOPE is a unique public-private partnership between a group of pertussis experts from 15 universities and 3 national public health institutes all over Europe, and 2 small medium enterprises and the European Federation of Pharmaceutical Industries and Associations (EFPIA) partners Sanofi Pasteur and GSK.

The consortium is supported by a joint programme of the European Union’s Horizon 2020 research and innovation agenda and the Innovative Medicines Initiative- 2 programme (H2020-IMI2) under agreement No 115910. Importantly, PERISCOPE is the first IMI project to also receive funding from the Bill & Melinda Gates Foundation (BMGF), which reflects the global importance of this project. 

Dutch PERISCOPE team

Dutch institutions involved include the Radboud university medical centre (Radboudumc), the Leiden University Medical Center (LUMC) and the National Institute for Public Health and the Environment (RIVM). 

Dutch IMI-PERISCOPE Team 584px 

Annemarie Buisman (RIVM), Guy Berbers (RIVM), Jacques van Dongen (LUmc), Martijn Huijnen (RUmc), Ronald de Groot (RUmc), Dimitri Diavatopoulos (RUmc), Céecile van Els (RIVM), Sacha van Hijum (RUmc) (Marjolein van Gent (RIVM, not in picture) 

RIVM Experts 

Annemarie Buisman 

Immunologist 

Guy Berbers 

Biochemist/Immunologist 

Cécile van Els 

Immunologist 

Marjolein van Gent 

Microbiologist  

 

Contact

Home / Topics / P / PERISCOPE / Consortium

RIVM Committed to health and sustainability
Menu